Whereas the Global Fund to fight AIDS, tuberculosis (TB), and malaria is an effective partnership of governments, the private sector, civil society, and affected communities to transform the response to these epidemics; Whereas since the Global Fund’s creation in 2002, and in close cooperation with the President’s Emergency Plan for AIDS Relief (PEPFAR), more than 27,000,000 lives have been saved in countries where the Global Fund invests; Whereas the Global Fund has contributed to extraordinary improvements in global health, including by helping to reduce by half the number of AIDS-related deaths since 2005, contributing to a 37-percent decline in TB deaths from 2000 to 2016, and a 60-percent decline in the number of malaria deaths since 2000; Whereas the Global Fund and its partners work to uphold a steadfast commitment to transparency and accountability, receiving high marks in multilateral aid reviews and by independent watchdogs; Whereas despite progress achieved to date in combating AIDS, TB, and malaria, significant challenges threaten future progress, including drug and insecticide resistance, reaching marginalized and vulnerable populations, and complacency in the fight against infectious diseases; Whereas United States leadership has been critical to the Global Fund’s success as its largest donor and through its oversight role on the Board of the Global Fund; Whereas the Global Fund amplifies and supports the results of United States bilateral heath programs, including the PEPFAR, the President’s Malaria Initiative, and the United States Agency for International Development TB program; Whereas a statutory cap on United States contributions to the Global Fund has successfully leveraged increased contributions from other donors in prior Global Fund replenishments and is expected to do so again during the Sixth Replenishment, to be held in Lyon, France, on October 19, 2019